T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.62B |
| 2 |
Ingersoll Rand
IR
|
+$2.99B |
| 3 |
Fortive
FTV
|
+$2.58B |
| 4 |
Apple
AAPL
|
+$2.46B |
| 5 |
Yum! Brands
YUM
|
+$2.1B |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.71% |
| 2 | Healthcare | 21.85% |
| 3 | Financials | 13.14% |
| 4 | Consumer Discretionary | 12.07% |
| 5 | Industrials | 11.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Belden
BDC
$5.36B
| $152M | 0.12% |
+2,530,136
| New | +$161M |
|
|
PYCR
177
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $151M | 0.12% |
+5,112,371
| New | +$148M |
|
178
Regal Rexnord
RRX
$11.5B
| $150M | 0.12% |
+1,067,809
| New | +$143M |
|
179
Cavco Industries
CVCO
$4.61B
| $150M | 0.12% |
+727,337
| New | +$172M |
|
|
BPMC
180
DELISTED
Blueprint Medicines
BPMC
| $149M | 0.12% |
+2,258,757
| New | +$145M |
|
181
CRISPR Therapeutics
CRSP
$5.18B
| $146M | 0.12% |
+2,241,445
| New | +$162M |
|
182
Match Group
MTCH
$8.36B
| $145M | 0.12% |
+3,037,501
| New | +$191M |
|
183
Constellium
CSTM
$3.96B
| $144M | 0.11% |
+14,158,265
| New | +$188M |
|
184
Xometry
XMTR
$5.42B
| $141M | 0.11% |
+2,485,329
| New | +$116M |
|
|
SEM
185
DELISTED
Select Medical
SEM
| $141M | 0.11% |
+11,839,372
| New | +$168M |
|
186
WSFS Financial
WSFS
$4.16B
| $140M | 0.11% |
+3,007,025
| New | +$141M |
|
|
BWIN
187
Baldwin Insurance Group
BWIN
$2.92B
| $139M | 0.11% |
+5,279,685
| New | +$150M |
|
188
UFP Industries
UFPI
$5.06B
| $137M | 0.11% |
+1,905,117
| New | +$152M |
|
189
Workiva
WK
$3.67B
| $137M | 0.11% |
+1,758,611
| New | +$120M |
|
|
XIFR
190
XPLR Infrastructure LP
XIFR
$1.08B
| $137M | 0.11% |
+1,892,052
| New | +$152M |
|
191
Liberty Energy
LBRT
$3.56B
| $135M | 0.11% |
+10,676,450
| New | +$144M |
|
|
DOCU
192
DocuSign
DOCU
$11.1B
| $135M | 0.11% |
+2,518,551
| New | +$158M |
|
193
BellRing Brands
BRBR
$1.25B
| $135M | 0.11% |
+6,527,020
| New | +$157M |
|
194
ONE Gas
OGS
$5.1B
| $134M | 0.11% |
+1,902,195
| New | +$153M |
|
195
Helios Technologies
HLIO
$2.68B
| $133M | 0.11% |
+2,638,271
| New | +$159M |
|
196
Warby Parker
WRBY
$3.18B
| $133M | 0.11% |
+9,999,215
| New | +$133M |
|
197
Toast
TOST
$19.7B
| $133M | 0.11% |
+7,950,369
| New | +$138M |
|
198
Harmonic Inc
HLIT
$1.42B
| $132M | 0.11% |
+10,131,817
| New | +$109M |
|
199
CTS Corp
CTS
$1.81B
| $132M | 0.11% |
+3,168,329
| New | +$127M |
|
|
SBNY
200
DELISTED
Signature Bank
SBNY
| $132M | 0.11% |
+871,918
| New | +$158M |
|
Similar funds
T. Rowe Price Investment Management's Q3 2022 Portfolio in Review
Q3 2022 is the first quarter with a 13F filing on record for T. Rowe Price Investment Management, which disclosed 541 positions worth $125B. Its ten largest holdings account for 18% of the portfolio.
Its largest position is Microsoft: 17,509,233 shares worth $4.08B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, followed by Healthcare and Financials.
- T. Rowe Price Investment Management's largest Q3 2022 buy was Microsoft: 17,509,233 shares worth $4.08B.
- T. Rowe Price Investment Management's ten largest holdings make up 18% of its $125B portfolio in Q3 2022.
- T. Rowe Price Investment Management disclosed 541 positions in Q3 2022, its first 13F filing on record.
Based on T. Rowe Price Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.